Expression of immune regulatory factors, chemokines and growth factors in differentiated gastric cancer cells treated with an anticancer bioactive peptide combined with oxaliplatin-Reference-Cited by-同舟云学术

Expression of immune regulatory factors, chemokines and growth factors in differentiated gastric cancer cells treated with an anticancer bioactive peptide combined with oxaliplatin

Published:2023-12-06 Issue:1 Volume:20 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Li Xian¹,Peng Jiaqi¹,Su Xiulan¹

Affiliation:

1. Key Laboratory of Medical Cell Biology in Inner Mongolia, Inner Mongolia Bioactive Peptide Engineering Laboratory, Clinical Medical Research Center, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference58 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Factors associated with recurrence and survival in N0 gastric cancer;Yang;Ann Surg,2017

3. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer;Zhang;Aging (Albany NY),2021

4. Dissecting the fatigue experience: A scoping review of fatigue definitions, dimensions, and measures in non-oncologic medical conditions;Billones;Brain Behav Immun Health,2021

5. Validation of the Chinese version of multidimensional fatigue Inventory-20 in Chinese patients with cancer;Tian;Support Care Cancer,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment;Frontiers in Immunology;2024-08-14